[ Price : $8.95]
FDA and the HHS Office for Human Research Protections issue draft guidance to help institutions and IRBs prepare and maintain meet...[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America chief medical officer William Chin says the U.S. is fortunate to have biophar...[ Price : $8.95]
Institute for Policy Innovation resident scholar Merrill Matthews says that competition, not regulation, is the best way to put do...[ Price : $8.95]
Stakeholders air their issues with an FDA discussion paper on promotion of laboratory data semantic interoperability.[ Price : $8.95]
FDA approves a Gilead Sciences NDA for Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine...[ Price : $8.95]
American Society for Bone and Mineral Research president Douglas Kiel says that outdated FDA requirements are stalling the develop...[ Price : $8.95]
Attorney Timothy Kearns says there are several reasons why recent Federal Trade Commission consent orders with Par and Concordia o...[ Price : $8.95]
Representative Mike Fitzpatrick (R-PA) introduces the E-Free Act that directs FDA to withdraw approval of Bayer Healths Essure per...